Khoa Nguyen-Dang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Khoa Nguyen-Dang has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Ngoc Duong-Minh
Department of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
8 shared publications - Quoc-Khanh Tran-Le
Department of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
6 shared publications - Nam Vu-Hoai
Department of Pulmonary Medicine, Cho Ray Hospital, Ho Chi Minh City, Vietnam
4 shared publications - Hanh-Duyen Bui-Thi
Department of Intensive Care, University Medical Center Ho Chi Minh City, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
3 shared publications Ngoc Duong-Minh
University Medical Center Ho Chi Minh City, Ho Chi Minh City, Viet Nam
3 shared publications- Nguyen Tran-Ngoc
Department of Tuberculosis and Lung Diseases, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
3 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 20
A rare TERT p.Ala880Thr variant associated with familial pulmonary fibrosis and multisystem involvement: Intrafamilial heterogeneity in a Vietnamese kindred – A case series
Short telomere syndromes (STS) are rare telomere biology disorders caused by germline variants affecting telomere maintenance and may present with organ-limited disease (e.g., pulmonary fibrosis) or multisystem involvement. We report a Vietnamese family carrying a heterozygous TERT p. Ala880Thr variant. The proband was a 42-year-old man with cryptogenic cirrhosis who was incidentally found to have a probable usual interstitial pneumonia (UIP) pattern on high-resolution computed tomography (HRCT) and later developed progressive interstitial lung disease (ILD). He also had marked premature graying, platypnea, digital clubbing, and hepatopulmonary syndrome. Cascade evaluation identified two monozygotic twin sisters (41 years) who also had ILD with discrepant severity: one symptomatic with probable UIP and FVC 47% predicted, while the other was asymptomatic with mild probable UIP changes and FVC 84% predicted. Further pedigree assessment identified maternal cryptogenic cirrhosis and two siblings who died in early childhood with transfusion-dependent anemia, suggesting additional hepatic and hematologic manifestations within the family. Panel-based targeted NGS identified the heterozygous TERT p. Ala880Thr variant in the proband and one affected twin sister, and targeted Sanger sequencing confirmed the familial variant in additional relatives. This case series provides detailed clinical and segregation data from a Vietnamese kindred carrying the previously reported TERT p. Ala880Thr variant. It also highlights the need to suspect telomere-related disease when ILD presents at a young age or is accompanied by extrapulmonary features such as cryptogenic liver disease, premature graying, or a suggestive family history. Early genetic testing and cascade counseling may improve recognition and longitudinal surveillance of at-risk relatives.
- 31 August 2026
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 20
Open AccessA rare TERT p.Ala880Thr variant associated with familial pulmonary fibrosis and multisystem involvement: Intrafamilial heterogeneity in a Vietnamese kindred – A case series
Short telomere syndromes (STS) are rare telomere biology disorders caused by germline variants affecting telomere maintenance and may present with organ-limited disease (e.g., pulmonary fibrosis) or multisystem involvement. We report a Vietnamese family carrying a heterozygous TERT p. Ala880Thr variant. The proband was a 42-year-old man with cryptogenic cirrhosis who was incidentally found to have a probable usual interstitial pneumonia (UIP) pattern on high-resolution computed tomography (HRCT) and later developed progressive interstitial lung disease (ILD). He also had marked premature graying, platypnea, digital clubbing, and hepatopulmonary syndrome. Cascade evaluation identified two monozygotic twin sisters (41 years) who also had ILD with discrepant severity: one symptomatic with probable UIP and FVC 47% predicted, while the other was asymptomatic with mild probable UIP changes and FVC 84% predicted. Further pedigree assessment identified maternal cryptogenic cirrhosis and two siblings who died in early childhood with transfusion-dependent anemia, suggesting additional hepatic and hematologic manifestations within the family. Panel-based targeted NGS identified the heterozygous TERT p. Ala880Thr variant in the proband and one affected twin sister, and targeted Sanger sequencing confirmed the familial variant in additional relatives. This case series provides detailed clinical and segregation data from a Vietnamese kindred carrying the previously reported TERT p. Ala880Thr variant. It also highlights the need to suspect telomere-related disease when ILD presents at a young age or is accompanied by extrapulmonary features such as cryptogenic liver disease, premature graying, or a suggestive family history. Early genetic testing and cascade counseling may improve recognition and longitudinal surveillance of at-risk relatives.
- Open Access
- 29 July 2026
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 20
Surgical management of refractory massive hemoptysis from pulmonary artery pseudoaneurysm due to Streptococcus constellatus : a rare case report and literature review
Pulmonary artery pseudoaneurysm (PAP) is a rare but potentially fatal vascular lesion resulting from focal disruption of the pulmonary arterial wall. Although hemoptysis from the pulmonary arterial system is uncommon, PAP carries a high risk of rupture, with reported mortality rates up to 50%. PAP is most often caused by trauma or infection, with pyogenic bacteria and fungi as typical pathogens, while Streptococcus constellatus is an exceptionally rare cause. A 60-year-old woman with well-controlled type 2 diabetes presented with recurrent massive hemoptysis, fever, and right-sided pleuritic chest pain, without prior lung disease or trauma. She initially underwent emergency bronchial artery embolization (BAE) and antibiotic therapy for necrotizing pneumonia-associated hemoptysis, with no clinical improvement. Following the second BAE for recurrent massive hemoptysis, a PAP, possibly related to a bronchial-pulmonary arterial shunt, was suspected in the right lower lobe on angiography and subsequently confirmed on contrast-enhanced computed tomography. Despite optimal medical therapy, repeated BAE, and coil embolization of the PAP, hemoptysis persisted, and respiratory status deteriorated. The patient ultimately underwent video-assisted thoracoscopic right lower lobectomy, with intraoperative cultures of lung tissue and pleural fluid confirming S. constellatus , and achieved complete recovery without recurrent hemoptysis. PAP is a rare but potentially fatal cause of hemoptysis that requires a high index of suspicion. Although endovascular intervention is effective for initial hemorrhage control, persistent infection or refractory hemoptysis may necessitate surgical resection to achieve definitive management. This case highlights S. constellatus as an exceptionally rare infectious cause of PAP and underscores the importance of a multidisciplinary approach in complex, antibiotic-resistant cases.
- 29 July 2026
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 20
Open AccessSurgical management of refractory massive hemoptysis from pulmonary artery pseudoaneurysm due to Streptococcus constellatus : a rare case report and literature review
Pulmonary artery pseudoaneurysm (PAP) is a rare but potentially fatal vascular lesion resulting from focal disruption of the pulmonary arterial wall. Although hemoptysis from the pulmonary arterial system is uncommon, PAP carries a high risk of rupture, with reported mortality rates up to 50%. PAP is most often caused by trauma or infection, with pyogenic bacteria and fungi as typical pathogens, while Streptococcus constellatus is an exceptionally rare cause. A 60-year-old woman with well-controlled type 2 diabetes presented with recurrent massive hemoptysis, fever, and right-sided pleuritic chest pain, without prior lung disease or trauma. She initially underwent emergency bronchial artery embolization (BAE) and antibiotic therapy for necrotizing pneumonia-associated hemoptysis, with no clinical improvement. Following the second BAE for recurrent massive hemoptysis, a PAP, possibly related to a bronchial-pulmonary arterial shunt, was suspected in the right lower lobe on angiography and subsequently confirmed on contrast-enhanced computed tomography. Despite optimal medical therapy, repeated BAE, and coil embolization of the PAP, hemoptysis persisted, and respiratory status deteriorated. The patient ultimately underwent video-assisted thoracoscopic right lower lobectomy, with intraoperative cultures of lung tissue and pleural fluid confirming S. constellatus , and achieved complete recovery without recurrent hemoptysis. PAP is a rare but potentially fatal cause of hemoptysis that requires a high index of suspicion. Although endovascular intervention is effective for initial hemorrhage control, persistent infection or refractory hemoptysis may necessitate surgical resection to achieve definitive management. This case highlights S. constellatus as an exceptionally rare infectious cause of PAP and underscores the importance of a multidisciplinary approach in complex, antibiotic-resistant cases.
- Open Access
- 19 March 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1) , 41
Bedside POCUS-guided Abrams pleural biopsy in the hands of respiratory physicians in a TB-endemic setting: diagnostic accuracy and safety
Background: With an estimated global incidence of 360 cases per 100,000 annually, pleural effusion is a substantial health burden. In TB-endemic, resource-limited settings, timely diagnosis remains challenging. When pleural fluid analysis and clinico-radiologic evaluation are nondiagnostic, pleural biopsy is often required. Blind closed pleural biopsy remains widely used; point-of-care ultrasound (POCUS) guidance may improve diagnostic yield while maintaining a favorable safety profile. Objective: To evaluate the diagnostic performance, technical success, and safety of POCUS-guided Abrams pleural biopsy in adults with exudative pleural effusion. Methods: We conducted a prospective diagnostic study of consecutive adults with undiagnosed exudative pleural effusion who underwent POCUS-guided Abrams pleural biopsy at the Respiratory Medicine Department, Cho Ray Hospital (October 2019-May 2020). The primary outcomes were diagnostic performance for malignant pleural effusion (MPE) and tuberculous pleural effusion (TPE) against a composite reference standard. Results: Among 117 patients, pleural tissue was successfully obtained in 116 (99.1%). Malignancy (59.8%) and tuberculosis (23.9%) were the leading etiologies. For MPE, POCUS-guided biopsy had a sensitivity of 61.4% and a specificity of 100%. For TPE, sensitivity was 57.1% and specificity was 100%. Sensitivity for malignancy was higher in patients with pleural thickening ≥ 3 mm than in those without significant thickening (80.8% vs. 50.0%; p = 0.01). The overall complication rate was 2.6%, comprising one pneumothorax (0.9%) and two vasovagal reactions (1.7%); no hemothorax, pleural infection, or intra-abdominal organ injury occurred. Conclusions: In this TB-endemic, resource-limited setting, POCUS-guided Abrams pleural biopsy achieved very high tissue yield and low complication rates, with moderate diagnostic sensitivity that improved substantially in the presence of pleural thickening. These findings support wider adoption of ultrasound-guided pleural biopsy as a safe, effective alternative to blind closed biopsy in similar settings.
- 19 March 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1) , 41
Open AccessBedside POCUS-guided Abrams pleural biopsy in the hands of respiratory physicians in a TB-endemic setting: diagnostic accuracy and safety
Background: With an estimated global incidence of 360 cases per 100,000 annually, pleural effusion is a substantial health burden. In TB-endemic, resource-limited settings, timely diagnosis remains challenging. When pleural fluid analysis and clinico-radiologic evaluation are nondiagnostic, pleural biopsy is often required. Blind closed pleural biopsy remains widely used; point-of-care ultrasound (POCUS) guidance may improve diagnostic yield while maintaining a favorable safety profile. Objective: To evaluate the diagnostic performance, technical success, and safety of POCUS-guided Abrams pleural biopsy in adults with exudative pleural effusion. Methods: We conducted a prospective diagnostic study of consecutive adults with undiagnosed exudative pleural effusion who underwent POCUS-guided Abrams pleural biopsy at the Respiratory Medicine Department, Cho Ray Hospital (October 2019-May 2020). The primary outcomes were diagnostic performance for malignant pleural effusion (MPE) and tuberculous pleural effusion (TPE) against a composite reference standard. Results: Among 117 patients, pleural tissue was successfully obtained in 116 (99.1%). Malignancy (59.8%) and tuberculosis (23.9%) were the leading etiologies. For MPE, POCUS-guided biopsy had a sensitivity of 61.4% and a specificity of 100%. For TPE, sensitivity was 57.1% and specificity was 100%. Sensitivity for malignancy was higher in patients with pleural thickening ≥ 3 mm than in those without significant thickening (80.8% vs. 50.0%; p = 0.01). The overall complication rate was 2.6%, comprising one pneumothorax (0.9%) and two vasovagal reactions (1.7%); no hemothorax, pleural infection, or intra-abdominal organ injury occurred. Conclusions: In this TB-endemic, resource-limited setting, POCUS-guided Abrams pleural biopsy achieved very high tissue yield and low complication rates, with moderate diagnostic sensitivity that improved substantially in the presence of pleural thickening. These findings support wider adoption of ultrasound-guided pleural biopsy as a safe, effective alternative to blind closed biopsy in similar settings.
- Open Access
- 20 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (8) , e47816
Short-term corticosteroid therapy in aspiration pneumonitis complicated by acute respiratory distress syndrome: A case report
Rationale: Aspiration of gastric contents (Mendelson syndrome) can cause chemical pneumonitis and quickly progress to acute respiratory distress syndrome (ARDS). Evidence for corticosteroids in this setting is limited, and guidelines are unclear. We describe a postpartum case of aspiration pneumonitis evolving to ARDS that improved after a short course of methylprednisolone. Patient concerns: A 27-year-old woman developed severe dyspnea, chest tightness, and hypoxemia after a cesarean section performed under general anesthesia. Diagnoses: On arrival at Cho Ray Hospital, she was tachypneic with bilateral crackles and a PaO 2 /FiO 2 ratio of 78.4. Chest radiography showed diffuse bilateral infiltrates, and bronchoscopy revealed edematous, secretion-free airways, findings consistent with aspiration pneumonitis progressing to early ARDS. Interventions: The patient was intubated, treated with lung-protective mechanical ventilation, broad-spectrum antibiotics, supportive care, and intravenous methylprednisolone at 1 mg/kg/day for 2 days. Outcomes: Oxygenation indices rose rapidly after steroid initiation, allowing stepwise ventilator weaning. She was extubated on day 5 and discharged on day 10 without respiratory symptoms, and postpartum recovery was uneventful. Lessons: Mendelson syndrome can progress within hours to severe ARDS even in otherwise healthy postpartum patients. Early airway protection with lung-protective ventilation, consideration of early bronchoscopy when feasible, and stewardship-based empiric antibiotics with de-escalation are important. A carefully monitored, time-limited corticosteroid trial may be considered in selected cases of chemical aspiration-related moderate to severe ARDS, but treatment should be individualized with close reassessment.
- 20 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (8) , e47816
Open AccessShort-term corticosteroid therapy in aspiration pneumonitis complicated by acute respiratory distress syndrome: A case report
Rationale: Aspiration of gastric contents (Mendelson syndrome) can cause chemical pneumonitis and quickly progress to acute respiratory distress syndrome (ARDS). Evidence for corticosteroids in this setting is limited, and guidelines are unclear. We describe a postpartum case of aspiration pneumonitis evolving to ARDS that improved after a short course of methylprednisolone. Patient concerns: A 27-year-old woman developed severe dyspnea, chest tightness, and hypoxemia after a cesarean section performed under general anesthesia. Diagnoses: On arrival at Cho Ray Hospital, she was tachypneic with bilateral crackles and a PaO 2 /FiO 2 ratio of 78.4. Chest radiography showed diffuse bilateral infiltrates, and bronchoscopy revealed edematous, secretion-free airways, findings consistent with aspiration pneumonitis progressing to early ARDS. Interventions: The patient was intubated, treated with lung-protective mechanical ventilation, broad-spectrum antibiotics, supportive care, and intravenous methylprednisolone at 1 mg/kg/day for 2 days. Outcomes: Oxygenation indices rose rapidly after steroid initiation, allowing stepwise ventilator weaning. She was extubated on day 5 and discharged on day 10 without respiratory symptoms, and postpartum recovery was uneventful. Lessons: Mendelson syndrome can progress within hours to severe ARDS even in otherwise healthy postpartum patients. Early airway protection with lung-protective ventilation, consideration of early bronchoscopy when feasible, and stewardship-based empiric antibiotics with de-escalation are important. A carefully monitored, time-limited corticosteroid trial may be considered in selected cases of chemical aspiration-related moderate to severe ARDS, but treatment should be individualized with close reassessment.
- Open Access
- 5 February 2026
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 20
Corynebacterium jeikeium empyema in an immunocompetent adult: first case report and literature review
Corynebacterium jeikeium is an uncommon but increasingly recognized cause of invasive infection, usually affecting immunocompromised patients. Empyema due to C. jeikeium has not been previously reported in an immunocompetent adult. We describe the first case and review the existing literature on non-diphtherial Corynebacterium -related empyema to highlight diagnostic and therapeutic challenges. A 26-year-old previously healthy man presented with 5 days of pleuritic chest pain, fever, and productive cough. Chest computed tomography revealed a large, loculated left pleural effusion with an air–fluid level. Initial thoracentesis yielded frank pus, confirming empyema, but the patient declined immediate drainage and was started on intravenous cefoperazone/sulbactam and moxifloxacin. His condition worsened, prompting repeat thoracentesis and catheter drainage. Culture of pleural fluid grew C. jeikeium , leading to a switch to intravenous vancomycin and meropenem. The patient improved rapidly, with defervescence, normalization of inflammatory markers, and complete radiographic resolution. He remained well at the 3-month follow-up. A literature review identified only four previous cases of non-diphtherial Corynebacterium-related empyema, all in patients with significant comorbidities. This case demonstrates that C. jeikeium can cause empyema even in immunocompetent hosts. Early microbiological diagnosis, timely pleural drainage, and appropriate antimicrobial therapy, particularly vancomycin, are critical for successful outcomes. Increased awareness and case reporting will help refine management strategies for this rare but clinically relevant pathogen.
- 5 February 2026
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 20
Open AccessCorynebacterium jeikeium empyema in an immunocompetent adult: first case report and literature review
Corynebacterium jeikeium is an uncommon but increasingly recognized cause of invasive infection, usually affecting immunocompromised patients. Empyema due to C. jeikeium has not been previously reported in an immunocompetent adult. We describe the first case and review the existing literature on non-diphtherial Corynebacterium -related empyema to highlight diagnostic and therapeutic challenges. A 26-year-old previously healthy man presented with 5 days of pleuritic chest pain, fever, and productive cough. Chest computed tomography revealed a large, loculated left pleural effusion with an air–fluid level. Initial thoracentesis yielded frank pus, confirming empyema, but the patient declined immediate drainage and was started on intravenous cefoperazone/sulbactam and moxifloxacin. His condition worsened, prompting repeat thoracentesis and catheter drainage. Culture of pleural fluid grew C. jeikeium , leading to a switch to intravenous vancomycin and meropenem. The patient improved rapidly, with defervescence, normalization of inflammatory markers, and complete radiographic resolution. He remained well at the 3-month follow-up. A literature review identified only four previous cases of non-diphtherial Corynebacterium-related empyema, all in patients with significant comorbidities. This case demonstrates that C. jeikeium can cause empyema even in immunocompetent hosts. Early microbiological diagnosis, timely pleural drainage, and appropriate antimicrobial therapy, particularly vancomycin, are critical for successful outcomes. Increased awareness and case reporting will help refine management strategies for this rare but clinically relevant pathogen.
- Open Access
- 2 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (1) , e45932
Emergence of Candida auris in Vietnam: A 3-year retrospective study from 2023 to 2025 at the Department of Pulmonary Medicine of Cho Ray Hospital
Candida auris is an emerging, multidrug-resistant fungal pathogen associated with severe infections, nosocomial outbreaks, and high mortality rates. Although its global prevalence is increasing, epidemiological and clinical data from Vietnam remain limited. This study provides the first characterization of C auris infections in Vietnam, highlighting clinical features, antifungal susceptibility, and outcomes to address a critical knowledge gap and inform local practice. A retrospective study was conducted at the Department of Pulmonary Medicine, Cho Ray Hospital, Vietnam, from January 2023 to July 2025. Adult patients (≥18 years) with confirmed C auris infection, identified from clinical specimens by MALDI-TOF MS, were included. Demographic, clinical, and microbiological data were extracted from medical records. Antifungal susceptibility was assessed using the ETEST method and interpreted according to the CDC breakpoints. Outcomes were defined as survival versus mortality at discharge. Statistical analyses were performed using STATA 15.1, with significance set at P < .05. Twenty-two patients were identified, with a median age of 67 years and 77.3% male. Most (81.8%) required intensive care, and all had underlying lung disease with pneumonia. The overall survival rate was 59.1%. Mortality was significantly associated with parenteral nutrition, malnutrition, hypoalbuminemia, and vasopressor use ( P < .05). Survivors more frequently exhibited co-isolation with non- auris Candida species ( P < .05). Antifungal susceptibility testing showed that most isolates remained sensitive, with fluconazole susceptibility observed in 86.4% of cases. This study represents the first report of C auris infections in Vietnam, demonstrating its clinical burden in patients with severe respiratory illness. Early detection, appropriate antifungal therapy, and nutritional optimization appear crucial for improving outcomes. Routine surveillance and larger multicenter studies are warranted to guide infection control and evidence-based management of C auris in resource-limited settings.
- 2 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (1) , e45932
Open AccessEmergence of Candida auris in Vietnam: A 3-year retrospective study from 2023 to 2025 at the Department of Pulmonary Medicine of Cho Ray Hospital
Candida auris is an emerging, multidrug-resistant fungal pathogen associated with severe infections, nosocomial outbreaks, and high mortality rates. Although its global prevalence is increasing, epidemiological and clinical data from Vietnam remain limited. This study provides the first characterization of C auris infections in Vietnam, highlighting clinical features, antifungal susceptibility, and outcomes to address a critical knowledge gap and inform local practice. A retrospective study was conducted at the Department of Pulmonary Medicine, Cho Ray Hospital, Vietnam, from January 2023 to July 2025. Adult patients (≥18 years) with confirmed C auris infection, identified from clinical specimens by MALDI-TOF MS, were included. Demographic, clinical, and microbiological data were extracted from medical records. Antifungal susceptibility was assessed using the ETEST method and interpreted according to the CDC breakpoints. Outcomes were defined as survival versus mortality at discharge. Statistical analyses were performed using STATA 15.1, with significance set at P < .05. Twenty-two patients were identified, with a median age of 67 years and 77.3% male. Most (81.8%) required intensive care, and all had underlying lung disease with pneumonia. The overall survival rate was 59.1%. Mortality was significantly associated with parenteral nutrition, malnutrition, hypoalbuminemia, and vasopressor use ( P < .05). Survivors more frequently exhibited co-isolation with non- auris Candida species ( P < .05). Antifungal susceptibility testing showed that most isolates remained sensitive, with fluconazole susceptibility observed in 86.4% of cases. This study represents the first report of C auris infections in Vietnam, demonstrating its clinical burden in patients with severe respiratory illness. Early detection, appropriate antifungal therapy, and nutritional optimization appear crucial for improving outcomes. Routine surveillance and larger multicenter studies are warranted to guide infection control and evidence-based management of C auris in resource-limited settings.
- Open Access
- 18 November 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 25 (1) , 530
Pulmonary mucormycosis complicated by necrotizing pneumonia secondary to an obstructive endobronchial tumor-like lesion: a case report and review of literature
Background Mucormycosis is a rare but life-threatening invasive fungal infection, most commonly affecting immunocompromised individuals, especially those with poorly controlled diabetes mellitus. Pulmonary mucormycosis (PM) represents the second most frequent clinical form after rhino-orbital-cerebral disease and carries a high mortality rate. Diagnosis is often delayed because its clinical and radiological manifestations overlap with other pulmonary infections and malignancies. Necrotizing pneumonia secondary to endobronchial mucormycosis is exceptionally rare, representing a distinct and severe form of pulmonary involvement, with only sporadic cases reported in the literature. Case presentation A 71-year-old female farmer with previously undiagnosed and poorly controlled diabetes presented with progressive dyspnea, fever, productive cough, and weight loss. Initial chest computed tomography demonstrated necrotizing pneumonia in the right lower lobe. Broad-spectrum antibiotics failed to improve her condition, and cultures for bacteria, fungi, and Mycobacterium tuberculosis were negative. Flexible bronchoscopy revealed an endobronchial mass with whitish pseudomembranes nearly occluding the right lower lobe bronchus. Biopsy was complicated by profuse bleeding, which was controlled with local adrenaline. Histopathological examination confirmed endobronchial mucormycosis with extensive tissue necrosis, and intravenous amphotericin B was promptly initiated. The patient was later transitioned to oral posaconazole, resulting in gradual clinical and radiological improvement. Follow-up imaging at three and six months demonstrated complete resolution. Conclusion This case illustrates a rare presentation of necrotizing pneumonia secondary to endobronchial mucormycosis in a diabetic patient. Histopathological confirmation remains essential for diagnosis, particularly in patients presenting with necrotizing pneumonia and mass-like airway lesions unresponsive to antibiotics. Early recognition, timely antifungal therapy, and prolonged follow-up with serial imaging are critical to achieving full recovery and preventing recurrence.
- 18 November 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 25 (1) , 530
Open AccessPulmonary mucormycosis complicated by necrotizing pneumonia secondary to an obstructive endobronchial tumor-like lesion: a case report and review of literature
Background Mucormycosis is a rare but life-threatening invasive fungal infection, most commonly affecting immunocompromised individuals, especially those with poorly controlled diabetes mellitus. Pulmonary mucormycosis (PM) represents the second most frequent clinical form after rhino-orbital-cerebral disease and carries a high mortality rate. Diagnosis is often delayed because its clinical and radiological manifestations overlap with other pulmonary infections and malignancies. Necrotizing pneumonia secondary to endobronchial mucormycosis is exceptionally rare, representing a distinct and severe form of pulmonary involvement, with only sporadic cases reported in the literature. Case presentation A 71-year-old female farmer with previously undiagnosed and poorly controlled diabetes presented with progressive dyspnea, fever, productive cough, and weight loss. Initial chest computed tomography demonstrated necrotizing pneumonia in the right lower lobe. Broad-spectrum antibiotics failed to improve her condition, and cultures for bacteria, fungi, and Mycobacterium tuberculosis were negative. Flexible bronchoscopy revealed an endobronchial mass with whitish pseudomembranes nearly occluding the right lower lobe bronchus. Biopsy was complicated by profuse bleeding, which was controlled with local adrenaline. Histopathological examination confirmed endobronchial mucormycosis with extensive tissue necrosis, and intravenous amphotericin B was promptly initiated. The patient was later transitioned to oral posaconazole, resulting in gradual clinical and radiological improvement. Follow-up imaging at three and six months demonstrated complete resolution. Conclusion This case illustrates a rare presentation of necrotizing pneumonia secondary to endobronchial mucormycosis in a diabetic patient. Histopathological confirmation remains essential for diagnosis, particularly in patients presenting with necrotizing pneumonia and mass-like airway lesions unresponsive to antibiotics. Early recognition, timely antifungal therapy, and prolonged follow-up with serial imaging are critical to achieving full recovery and preventing recurrence.
- Open Access
- 12 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (37) , e44581
The value of scoring systems in predicting respiratory intensive care unit admission and 30-day mortality in hospitalized community-acquired pneumonia: A prospective study
This study aims to compare the predictive performance of 5 commonly used severity scoring systems, pneumonia severity index (PSI), SMART-COP, Infectious Diseases Society of America and American Thoracic Society (IDSA/ATS) 2007 minor criteria, simplified minor criteria, and modified minor criteria, in identifying 30-day all-cause mortality and the need for respiratory intensive care unit (RICU) admission among hospitalized patients with community-acquired pneumonia (CAP) in Vietnam. This prospective study was conducted at the Department of Pulmonary Medicine, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, from October 2019 to May 2020. We enrolled 101 hospitalized patients with CAP based on clinical and radiographic criteria. Multiple clinical scoring systems (PSI, SMART-COP, IDSA/ATS 2007, simplified and modified versions) were applied to assess 30-day all-cause mortality and RICU needs. Receiver operating characteristic curve analysis was used to evaluate the discriminatory ability of different scoring systems in predicting RICU admission and 30-day all-cause mortality. The area under the receiver operating characteristic curve (AUC) and P -values were calculated for each score. A total of 101 hospitalized patients were included, with a median age of 72. Common symptoms were productive cough, dyspnea, and fever (about 80%). Those admitted to RICU had a significantly higher prevalence of cerebrovascular disease, cognitive impairment, respiratory rates ≥ 30 bpm, and systolic blood pressure < 90 mm Hg, as well as worse laboratory findings, including elevated creatinine, blood urea nitrogen ≥ 7 mmol/L, hypoalbuminemia, multilobar chest radiographic involvement, and PaO 2 /FiO 2 ratio ≤ 250. Overall, 29.7% of patients died within 30 days. Non-survivors had a significantly higher prevalence of cerebrovascular disease, cognitive impairment, respiratory rates ≥ 30 bpm, blood urea nitrogen ≥ 7 mmol/L, and PaO 2 /FiO 2 ratio ≤ 250. IDSA/ATS 2007 minor criteria had the highest AUC for RICU prediction (0.815), while PSI best predicted 30-day mortality (AUC = 0.774). PSI score demonstrated the highest accuracy in predicting 30-day all-cause mortality among hospitalized patients with CAP. Meanwhile, IDSA/ATS 2007 minor criteria were most effective in predicting RICU admission.
- 12 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (37) , e44581
Open AccessThe value of scoring systems in predicting respiratory intensive care unit admission and 30-day mortality in hospitalized community-acquired pneumonia: A prospective study
This study aims to compare the predictive performance of 5 commonly used severity scoring systems, pneumonia severity index (PSI), SMART-COP, Infectious Diseases Society of America and American Thoracic Society (IDSA/ATS) 2007 minor criteria, simplified minor criteria, and modified minor criteria, in identifying 30-day all-cause mortality and the need for respiratory intensive care unit (RICU) admission among hospitalized patients with community-acquired pneumonia (CAP) in Vietnam. This prospective study was conducted at the Department of Pulmonary Medicine, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, from October 2019 to May 2020. We enrolled 101 hospitalized patients with CAP based on clinical and radiographic criteria. Multiple clinical scoring systems (PSI, SMART-COP, IDSA/ATS 2007, simplified and modified versions) were applied to assess 30-day all-cause mortality and RICU needs. Receiver operating characteristic curve analysis was used to evaluate the discriminatory ability of different scoring systems in predicting RICU admission and 30-day all-cause mortality. The area under the receiver operating characteristic curve (AUC) and P -values were calculated for each score. A total of 101 hospitalized patients were included, with a median age of 72. Common symptoms were productive cough, dyspnea, and fever (about 80%). Those admitted to RICU had a significantly higher prevalence of cerebrovascular disease, cognitive impairment, respiratory rates ≥ 30 bpm, and systolic blood pressure < 90 mm Hg, as well as worse laboratory findings, including elevated creatinine, blood urea nitrogen ≥ 7 mmol/L, hypoalbuminemia, multilobar chest radiographic involvement, and PaO 2 /FiO 2 ratio ≤ 250. Overall, 29.7% of patients died within 30 days. Non-survivors had a significantly higher prevalence of cerebrovascular disease, cognitive impairment, respiratory rates ≥ 30 bpm, blood urea nitrogen ≥ 7 mmol/L, and PaO 2 /FiO 2 ratio ≤ 250. IDSA/ATS 2007 minor criteria had the highest AUC for RICU prediction (0.815), while PSI best predicted 30-day mortality (AUC = 0.774). PSI score demonstrated the highest accuracy in predicting 30-day all-cause mortality among hospitalized patients with CAP. Meanwhile, IDSA/ATS 2007 minor criteria were most effective in predicting RICU admission.
- Open Access
- 24 July 2025
- Published by Vietnam Medical Journal, Vietnam Medical Association in Tạp chí Y học Việt Nam
- Vol. 552 (2)
ĐẶC ĐIỂM LÂM SÀNG VÀ CẬN LÂM SÀNG CỦA BỆNH NHÂN HEN TẠI PHÒNG KHÁM NGOẠI TRÚ BỆNH VIỆN MEDIC CÀ MAU
Mục tiêu: Mô tả đặc điểm lâm sàng và cận lâm sàng của bệnh nhân hen được chẩn đoán và điều trị tại phòng khám hen Bệnh viện Medic Cà Mau, đồng thời đánh giá những thuận lợi và khó khăn của mô hình quản lý hen tại tuyến y tế cơ sở. Đối tượng và phương pháp: Nghiên cứu mô tả thực hiện tại phòng khám hen từ tháng 6 đến tháng 12 năm 2024. Đối tượng bao gồm các bệnh nhân ≥18 tuổi được chẩn đoán hen theo tiêu chuẩn GINA 2024 và Bộ Y tế, có đầy đủ dữ liệu lâm sàng, X-quang ngực và hô hấp ký, và được theo dõi ít nhất một lần sau điều trị. Mô hình phòng khám đảm bảo quy trình chuẩn hóa từ chẩn đoán đến theo dõi điều trị do bác sĩ chuyên khoa Hô Hấp thực hiện. Kết quả: Có 46 bệnh nhân hen được đưa vào phân tích với tuổi trung bình 49,6 ± 16,8. Các triệu chứng phổ biến nhất là ho (71,7%), khó thở (65,2%), khò khè (54,3%) và nặng ngực (37%). Phần lớn bệnh nhân có X-quang ngực bình thường (95,7%) và đáp ứng điều trị (93,5%). Hô hấp ký cho thấy 67,4% trường hợp có tắc nghẽn đường thở, trong đó 54,3% có đáp ứng với test giãn phế quản. Phác đồ điều trị chủ yếu là liều trung bình ICS/LABA. Kết luận: Phần lớn bệnh nhân hen tại tuyến y tế cơ sở được phát hiện ở giai đoạn sớm và có thể kiểm soát hiệu quả nếu được can thiệp kịp thời. Tỉ lệ đáp ứng điều trị cao cho thấy tiềm năng của tuyến cơ sở trong quản lý hen, đồng thời nhấn mạnh nhu cầu nâng cao năng lực chuyên môn và quản lý y tế.
- 24 July 2025
- Published by Vietnam Medical Journal, Vietnam Medical Association in Tạp chí Y học Việt Nam
- Vol. 552 (2)
Open AccessĐẶC ĐIỂM LÂM SÀNG VÀ CẬN LÂM SÀNG CỦA BỆNH NHÂN HEN TẠI PHÒNG KHÁM NGOẠI TRÚ BỆNH VIỆN MEDIC CÀ MAU
Mục tiêu: Mô tả đặc điểm lâm sàng và cận lâm sàng của bệnh nhân hen được chẩn đoán và điều trị tại phòng khám hen Bệnh viện Medic Cà Mau, đồng thời đánh giá những thuận lợi và khó khăn của mô hình quản lý hen tại tuyến y tế cơ sở. Đối tượng và phương pháp: Nghiên cứu mô tả thực hiện tại phòng khám hen từ tháng 6 đến tháng 12 năm 2024. Đối tượng bao gồm các bệnh nhân ≥18 tuổi được chẩn đoán hen theo tiêu chuẩn GINA 2024 và Bộ Y tế, có đầy đủ dữ liệu lâm sàng, X-quang ngực và hô hấp ký, và được theo dõi ít nhất một lần sau điều trị. Mô hình phòng khám đảm bảo quy trình chuẩn hóa từ chẩn đoán đến theo dõi điều trị do bác sĩ chuyên khoa Hô Hấp thực hiện. Kết quả: Có 46 bệnh nhân hen được đưa vào phân tích với tuổi trung bình 49,6 ± 16,8. Các triệu chứng phổ biến nhất là ho (71,7%), khó thở (65,2%), khò khè (54,3%) và nặng ngực (37%). Phần lớn bệnh nhân có X-quang ngực bình thường (95,7%) và đáp ứng điều trị (93,5%). Hô hấp ký cho thấy 67,4% trường hợp có tắc nghẽn đường thở, trong đó 54,3% có đáp ứng với test giãn phế quản. Phác đồ điều trị chủ yếu là liều trung bình ICS/LABA. Kết luận: Phần lớn bệnh nhân hen tại tuyến y tế cơ sở được phát hiện ở giai đoạn sớm và có thể kiểm soát hiệu quả nếu được can thiệp kịp thời. Tỉ lệ đáp ứng điều trị cao cho thấy tiềm năng của tuyến cơ sở trong quản lý hen, đồng thời nhấn mạnh nhu cầu nâng cao năng lực chuyên môn và quản lý y tế.
- Open Access
- 1 July 2025
- Published by SAGE Publications in Therapeutic Advances in Hematology
- Vol. 16
Exploring the interchangeable roles of fibrinogen and FIBTEM in patients with sepsis
Background: FIBTEM, a rotational thromboelastometry (ROTEM) component, assesses fibrin-based clot firmness and indirectly measures fibrinogen function. It offers faster turnaround time compared to the Clauss method for fibrinogen quantification, which may support early coagulation assessment in critically ill patients with sepsis. Objectives: Our study aims to evaluate the correlation between FIBTEM parameters and fibrinogen levels and predict the possibility of hyperfibrinogenemia using FIBTEM parameters in patients with sepsis. Design: A retrospective secondary analysis of a prospective observational study. Methods: Patients diagnosed with sepsis were recruited and admitted to the University Medical Center Ho Chi Minh City intensive care unit from June 2020 to December 2021. The international normalized ratio, activated partial thromboplastin time, platelet counts, fibrinogen levels, and FIBTEM parameters (A5, A10, A20, and maximum clot firmness (MCF)) were assessed for each patient. The correlations among laboratory parameters were assessed using the Pearson’s correlation coefficient. Predicted values of fibrinogen and FIBTEM were analyzed using simple linear regression, Bland–Altman plots, and Lin’s concordance correlation coefficient (CCC). The area under the receiver operating characteristic curve (AUC) and Kappa coefficients were calculated. Results: The median age of 159 patients with sepsis was 69. Males represented 51.6% of the participants. The percentage of patients with comorbidities was 88.1%. The mean plasma fibrinogen level was 5.4 ± 1.8 g/L. Fibrinogen levels were strongly correlated with FIBTEM parameters ( p < 0.01 for all values), including A5 ( r = 0.701), A10 ( r = 0.717), A20 ( r = 0.723), and MCF ( r = 0.735). MCF could not predict exact fibrinogen levels (CCC = 0.703). The AUC of the MCF to predict hyperfibrinogenemia was 0.905 (95% CI: 0.866–0.945), with a sensitivity of 85.5%, a specificity of 83.1%, and a Kappa coefficient of 0.69 at the optimal cut-off value of 22.5 mm. Conclusion: FIBTEM MCF could be a practical, rapid, surrogate tool for detecting hyperfibrinogenemia in sepsis and may help guide early clinical decisions before fibrinogen test results are available, although further validation in larger studies is required.
- 1 July 2025
- Published by SAGE Publications in Therapeutic Advances in Hematology
- Vol. 16
Open AccessExploring the interchangeable roles of fibrinogen and FIBTEM in patients with sepsis
Background: FIBTEM, a rotational thromboelastometry (ROTEM) component, assesses fibrin-based clot firmness and indirectly measures fibrinogen function. It offers faster turnaround time compared to the Clauss method for fibrinogen quantification, which may support early coagulation assessment in critically ill patients with sepsis. Objectives: Our study aims to evaluate the correlation between FIBTEM parameters and fibrinogen levels and predict the possibility of hyperfibrinogenemia using FIBTEM parameters in patients with sepsis. Design: A retrospective secondary analysis of a prospective observational study. Methods: Patients diagnosed with sepsis were recruited and admitted to the University Medical Center Ho Chi Minh City intensive care unit from June 2020 to December 2021. The international normalized ratio, activated partial thromboplastin time, platelet counts, fibrinogen levels, and FIBTEM parameters (A5, A10, A20, and maximum clot firmness (MCF)) were assessed for each patient. The correlations among laboratory parameters were assessed using the Pearson’s correlation coefficient. Predicted values of fibrinogen and FIBTEM were analyzed using simple linear regression, Bland–Altman plots, and Lin’s concordance correlation coefficient (CCC). The area under the receiver operating characteristic curve (AUC) and Kappa coefficients were calculated. Results: The median age of 159 patients with sepsis was 69. Males represented 51.6% of the participants. The percentage of patients with comorbidities was 88.1%. The mean plasma fibrinogen level was 5.4 ± 1.8 g/L. Fibrinogen levels were strongly correlated with FIBTEM parameters ( p < 0.01 for all values), including A5 ( r = 0.701), A10 ( r = 0.717), A20 ( r = 0.723), and MCF ( r = 0.735). MCF could not predict exact fibrinogen levels (CCC = 0.703). The AUC of the MCF to predict hyperfibrinogenemia was 0.905 (95% CI: 0.866–0.945), with a sensitivity of 85.5%, a specificity of 83.1%, and a Kappa coefficient of 0.69 at the optimal cut-off value of 22.5 mm. Conclusion: FIBTEM MCF could be a practical, rapid, surrogate tool for detecting hyperfibrinogenemia in sepsis and may help guide early clinical decisions before fibrinogen test results are available, although further validation in larger studies is required.